Show simple item record

dc.contributor.authorSchutte, A.E.en_US
dc.contributor.authorSchutte, R.en_US
dc.contributor.authorHuisman, H.W.en_US
dc.contributor.authorVan Rooyen, J.M.en_US
dc.contributor.authorMalan, L.en_US
dc.contributor.authorOlckers, A.en_US
dc.contributor.authorMalan, N.T.en_US
dc.date.accessioned2010-08-04T15:35:58Z
dc.date.available2010-08-04T15:35:58Z
dc.date.issued2009en_US
dc.identifier.citationSchutte, A.E. et al. 2009. Classifying Africans with the metabolic syndrome. Hormone and Metabolic Research, 41(2):79-85. [https://doi.org/10.1055/s-0028-1104603]en_US
dc.identifier.issn0018-5043
dc.identifier.urihttp://hdl.handle.net/10394/3322
dc.identifier.urihttps://doi.org/10.1055/s-0028-1104603
dc.description.abstractThis study was aimed to compare prevalences of the metabolic syndrome in Africans using five definitions as proposed by the World Health Organization (WHO), the European Group for the Study of Insulin Resistance (EGIR), the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults [Adult Treatment Panel (ATPIII)], the American College of Endocrinology (ACE), and the International Diabetes Federation (IDF). A further objective was to identify difficulties in classifying Africans with the metabolic syndrome and to suggest specific areas where criteria adjustments for identifying Africans should be made. A case-case-control cross-sectional study involved 102 urban African women. Except for microalbumin data, all data necessary for classification of the metabolic syndrome were collected, including fasting and 2-h glucose and insulin, anthropometric measurements, blood pressure, and lipids. The metabolic syndrome prevalences ranged from 5.4% (EGIR), 15.7% (ATPIII), >or=19.4% (WHO), 24.8% (IDF) to 25.5% (ACE). Only 2.9% (n=3) had a triglyceride level >or=1.69 mmol/l, but 58.8% (n=60) had a HDL-level <1.29 mmol/l, whereas 27% (n=26) were insulin resistant, 22.3% (n=21), had a blood pressure >or=140/90 or used hypertension medication. It seems as if the classification of hypertension, insulin resistance and hyperglycemia might have been adequate, but body composition and dyslipidemia criteria need adjustment for Africans. Since neither definition seems completely suitable for Africans it is suggested that clinical emphasis should rather be on treating any specific cardiovascular disease risk factor that is present, than on diagnosing a patient with the metabolic syndrome.
dc.publisherThieme
dc.titleClassifying Africans with the Metabolic Syndromeen_US
dc.contributor.researchID10056173 - Malan, Nicolaas Theodor
dc.contributor.researchID10060871 - Malan, Leoné
dc.contributor.researchID10062718 - Huisman, Hugo Willem
dc.contributor.researchID10922180 - Schutte, Aletta Elisabeth
dc.contributor.researchID12201405 - Schutte, Rudolph
dc.contributor.researchID10059539 - Van Rooyen, Johannes Marthinus


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record